PMC5786925_01
(A) Chest CT image before starting trastuzumab plus lapatinib. (B) Chest CT image after 8 weeks of trastuzumab plus lapatinib therapy.
esmoopen-2017-000299f01.jpg
PMC5786925_01_esmoopen-2017-000299f01.jpg
F1
The first CT scan reassessment demonstrated a PR (figure 1), which lasted until September 2015 with a total of 16 courses of trastuzumab and lapatinib administered and a PFS of 12 months.